BENTIROMIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for bentiromide and what is the scope of freedom to operate?
Bentiromide
is the generic ingredient in one branded drug marketed by Savage Labs and is included in one NDA. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for bentiromide.
Summary for BENTIROMIDE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 39 |
| DailyMed Link: | BENTIROMIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for BENTIROMIDE
US Patents and Regulatory Information for BENTIROMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Savage Labs | CHYMEX | bentiromide | SOLUTION;ORAL | 018366-001 | Dec 29, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BENTIROMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Savage Labs | CHYMEX | bentiromide | SOLUTION;ORAL | 018366-001 | Dec 29, 1983 | ⤷ Start Trial | ⤷ Start Trial |
| Savage Labs | CHYMEX | bentiromide | SOLUTION;ORAL | 018366-001 | Dec 29, 1983 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
